Vectorcide

British business may have taken a dual hit of late, with the twin difficulties of Brexit and the global Coronavirus pandemic leaving much of the company’s economy reeling, but some companies have not just survived the lockdown but could accurately be said to have also thrived.

One such company is Vectorcide International Ltd. This London based research and development company has been focusing its effort on the last few years on eradicating diseases like Malaria and Dengue Fever, by focusing on eradicating the female mosquitoes that carry these deadly diseases.

Worldwide, Malaria carries an annual death toll of around 400,000 fatalities. In this time of global pandemics, where we may be getting numb to news of daily death counts, that’s still a shocking and thought-provoking figure. On World Malaria Day, in April 2020, the WHO announced they would join ‘Roll Back Malaria Partnership’ – an important milestone in the global fight against this killer disease.

Another important milestone has been the increasing use of Vectorcide’s patented VC-Coating in new-build housing projects across Africa, Pakistan and India. Vectorcide’s advanced formulas, borne out of years of research, ensure that people within these countries – as well as the 40 others the company operates in – are not exposed to the deadly mosquitoes

Vectorcide International Spokesperson,Ian Domville, says: ‘Vectorcide coating fills an important gap in the marketplace that exists because, frankly, insects are clever. Over time they become resistant to most forms of insecticide, usually as a result of genetic mutations. That means that traditionally people would layer even more harmful chemicals on top to stand a chance of killing the mosquito, but of course, they’re doing immeasurable harm to their lungs and bodies along the way.’

Vectorcide’s patented insecticidal coating is a totally safe, harmless to humans product, that kills mosquitoes when applied to the ceilings/walls of rooms where mosquitoes would normally be found. One application is more than sufficient for a 12-month period and will continue killing mosquitoes at over 99% effectiveness for the whole of that time.

This means that a safe, harmless to people and the wider environment, yet totally effective treatment is available and that finally, the battle against Malaria stands a chance of being won.